江苏安必生制药

Anbeishine Pharmaceutical is a specialty pharmaceutical company headquartered in China, dedicated to the development and manufacturing of high-end generic drugs and complex formulations. Founded by industry experts with extensive experience in multinational pharmaceutical firms, the company focuses on Quality by Design to meet international standards, including those of the US FDA and China's NMPA. Their portfolio includes several first-to-market generics in China, with a strong emphasis on therapeutic areas such as infectious diseases, neurology, and cardiovascular health. Anbeishine is recognized for its successful dual-submission strategy, having secured multiple ANDA approvals in the United States. The company operates a state-of-the-art manufacturing facility in Taizhou's China Medical City and an R&D center in Shanghai.